节点文献
平消胶囊配合化疗治疗中晚期肺癌疗效观察
Clinical study on the treatment of advanced lung cancer with Pingxiao capsule combined with chemotherapy
【摘要】 目的:探讨平消胶囊配合化疗治疗中晚期肺癌的效果。方法:选择106例肺癌患者,随机分为两组,进行临床疗效观察,治疗组54例,用平消胶囊配合化疗,患者在化疗前3天开始口服平消胶囊,每次6~8粒,每天3次,连服8周以上。对照组52例单用化疗。结果:治疗组有效率(CR+PR)57.4%,对照组有效率36.5%,两组有效率有显著性差异(P<0.05)。治疗组症状改善率81.5%,对照组症状改善率53.9%,两组有显著性差异(P<0.05)。毒副反应治疗组较对照组明显少而轻。结论:平消胶囊配合化疗治疗中晚期肺癌,对治疗有明显的增效作用,并能减轻毒副作用,提高生存质量,具有临床应用的价值。
【Abstract】 Objective:To explore the effective therapeutical method in treating advanced lung cancer.Methods:Total of 106 patients with lung cancer were enrolled in our study and were randomly divided into the treatment group,which consisted of 54 cases using Pingxiao capsule combined with chemotherapy,and the control group in which the patients were only treated by chemotherapy.The patients in the treatment group were advised to take 6~8 Pingxiao capsules,three times per day three-day prior to chemotherapy and the regimen continued 8 weeks.Results:The effective rate(CR+PR) in the treatment group was significantly higher than that in the control group(57.4% vs 36.5%,P<0.05),and so did the improved rates(81.5% vs 53.9%,P<0.05).The side effects in the treatment group were less and milder than those in the control group.Conclusion:Pingxiao capsule plays a significant role of enhancing chemotherapy,and improvding the adverse effects of chemotherapy.
- 【文献出处】 现代肿瘤医学 ,Journal of Modern Oncology , 编辑部邮箱 ,2007年08期
- 【分类号】R734.2
- 【被引频次】6
- 【下载频次】76